Allena Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ALNAQ and buy or sell other stocks, ETFs, and their options commission-free!About ALNAQ
Allena Pharmaceuticals, Inc. engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease.
CEOLouis Brenner, MD, MBA
CEOLouis Brenner, MD, MBA
Employees—
Employees—
HeadquartersSudbury, Massachusetts
HeadquartersSudbury, Massachusetts
Founded2011
Founded2011
Employees—
Employees—
ALNAQ Key Statistics
Market cap100.00
Market cap100.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume19.55K
Average volume19.55K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0185
52 Week high$0.0185
52 Week low—
52 Week low—
Stock Snapshot
As of today, Allena Pharmaceuticals(ALNAQ) shares are valued at $0.00. The company's market cap stands at 100.
During the trading day, Allena Pharmaceuticals(ALNAQ) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 19.55K.
People also own
Based on the portfolios of people who own ALNAQ. This list is generated using Robinhood data, and it’s not a recommendation.